Effect of invariant chain on major histocompatibility complex class i molecule expression and stability on human breast tumor cell lines

Xuede Lin, Xiaojian Wang, Haley L. Capek, Laura C. Simone, Amit Tuli, Chantey R. Morris, Adrian J. Reber, Joyce C Solheim

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Invariant chain (Ii) binds to the human leukocyte antigen (HLA) class II molecule and assists it in the process of peptide acquisition. In addition, Ii binds to the HLA class I molecule, although there has been little study of its effects on the HLA class I molecule. In addition to its normal expression on antigen-presenting cells, Ii expression is up regulated in a variety of tumors. By flow cytometric analysis, we found that expression of Ii resulted in an increase in the number of cell surface HLA class I molecules and in the proportion of unstable HLA class I molecules at the surface of breast tumor cell lines. These data suggest that the expression of Ii by tumor cells may quantitatively and qualitatively alter the presentation of antigens on those cells.

Original languageEnglish (US)
Pages (from-to)729-736
Number of pages8
JournalCancer Immunology, Immunotherapy
Volume58
Issue number5
DOIs
StatePublished - May 1 2009

Fingerprint

HLA Antigens
Tumor Cell Line
Major Histocompatibility Complex
Breast Neoplasms
Antigen Presentation
Antigen-Presenting Cells
Neoplasms
Cell Count
invariant chain
Peptides

Keywords

  • Antigen presentation
  • Antigens/peptides/epitopes
  • Breast cancer
  • Invariant chain
  • MHC class I molecule

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Oncology
  • Cancer Research

Cite this

Effect of invariant chain on major histocompatibility complex class i molecule expression and stability on human breast tumor cell lines. / Lin, Xuede; Wang, Xiaojian; Capek, Haley L.; Simone, Laura C.; Tuli, Amit; Morris, Chantey R.; Reber, Adrian J.; Solheim, Joyce C.

In: Cancer Immunology, Immunotherapy, Vol. 58, No. 5, 01.05.2009, p. 729-736.

Research output: Contribution to journalArticle

Lin, Xuede ; Wang, Xiaojian ; Capek, Haley L. ; Simone, Laura C. ; Tuli, Amit ; Morris, Chantey R. ; Reber, Adrian J. ; Solheim, Joyce C. / Effect of invariant chain on major histocompatibility complex class i molecule expression and stability on human breast tumor cell lines. In: Cancer Immunology, Immunotherapy. 2009 ; Vol. 58, No. 5. pp. 729-736.
@article{cf43e911e31b46a5b55c6564c6d86eae,
title = "Effect of invariant chain on major histocompatibility complex class i molecule expression and stability on human breast tumor cell lines",
abstract = "Invariant chain (Ii) binds to the human leukocyte antigen (HLA) class II molecule and assists it in the process of peptide acquisition. In addition, Ii binds to the HLA class I molecule, although there has been little study of its effects on the HLA class I molecule. In addition to its normal expression on antigen-presenting cells, Ii expression is up regulated in a variety of tumors. By flow cytometric analysis, we found that expression of Ii resulted in an increase in the number of cell surface HLA class I molecules and in the proportion of unstable HLA class I molecules at the surface of breast tumor cell lines. These data suggest that the expression of Ii by tumor cells may quantitatively and qualitatively alter the presentation of antigens on those cells.",
keywords = "Antigen presentation, Antigens/peptides/epitopes, Breast cancer, Invariant chain, MHC class I molecule",
author = "Xuede Lin and Xiaojian Wang and Capek, {Haley L.} and Simone, {Laura C.} and Amit Tuli and Morris, {Chantey R.} and Reber, {Adrian J.} and Solheim, {Joyce C}",
year = "2009",
month = "5",
day = "1",
doi = "10.1007/s00262-008-0595-1",
language = "English (US)",
volume = "58",
pages = "729--736",
journal = "Cancer Immunology and Immunotherapy",
issn = "0340-7004",
publisher = "Springer Science and Business Media Deutschland GmbH",
number = "5",

}

TY - JOUR

T1 - Effect of invariant chain on major histocompatibility complex class i molecule expression and stability on human breast tumor cell lines

AU - Lin, Xuede

AU - Wang, Xiaojian

AU - Capek, Haley L.

AU - Simone, Laura C.

AU - Tuli, Amit

AU - Morris, Chantey R.

AU - Reber, Adrian J.

AU - Solheim, Joyce C

PY - 2009/5/1

Y1 - 2009/5/1

N2 - Invariant chain (Ii) binds to the human leukocyte antigen (HLA) class II molecule and assists it in the process of peptide acquisition. In addition, Ii binds to the HLA class I molecule, although there has been little study of its effects on the HLA class I molecule. In addition to its normal expression on antigen-presenting cells, Ii expression is up regulated in a variety of tumors. By flow cytometric analysis, we found that expression of Ii resulted in an increase in the number of cell surface HLA class I molecules and in the proportion of unstable HLA class I molecules at the surface of breast tumor cell lines. These data suggest that the expression of Ii by tumor cells may quantitatively and qualitatively alter the presentation of antigens on those cells.

AB - Invariant chain (Ii) binds to the human leukocyte antigen (HLA) class II molecule and assists it in the process of peptide acquisition. In addition, Ii binds to the HLA class I molecule, although there has been little study of its effects on the HLA class I molecule. In addition to its normal expression on antigen-presenting cells, Ii expression is up regulated in a variety of tumors. By flow cytometric analysis, we found that expression of Ii resulted in an increase in the number of cell surface HLA class I molecules and in the proportion of unstable HLA class I molecules at the surface of breast tumor cell lines. These data suggest that the expression of Ii by tumor cells may quantitatively and qualitatively alter the presentation of antigens on those cells.

KW - Antigen presentation

KW - Antigens/peptides/epitopes

KW - Breast cancer

KW - Invariant chain

KW - MHC class I molecule

UR - http://www.scopus.com/inward/record.url?scp=61349113974&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61349113974&partnerID=8YFLogxK

U2 - 10.1007/s00262-008-0595-1

DO - 10.1007/s00262-008-0595-1

M3 - Article

VL - 58

SP - 729

EP - 736

JO - Cancer Immunology and Immunotherapy

JF - Cancer Immunology and Immunotherapy

SN - 0340-7004

IS - 5

ER -